Halozyme Therapeutics Price Chart
Halozyme Therapeutics Volume Chart
Halozyme Therapeutics Market Segments
Regular Trading Hours
-0.84(-1.23%)
| Open | $68.03 |
|---|---|
| Close | $67.19 |
| Low | $67.09 |
| Low Change | -0.94 (-1.38%) |
| High | $69.32 |
| High Change | +1.29 (+1.90%) |
| Range | $2.23 |
| Volume | 818.241K |
| Dollar Volume | $54.98M |
Premarket
+0.80(+1.18%)
| Open | $67.98 |
|---|---|
| Close | $68.78 |
| Low | $67.12 |
| Low Change | -0.86 (-1.27%) |
| High | $68.80 |
| High Change | +0.82 (+1.21%) |
| Range | $1.68 |
| Volume | 4.942K |
| Dollar Volume | $339.91K |
After Hours Yesterday
-0.02(-0.03%)
| Open | $67.12 |
|---|---|
| Close | $67.10 |
| Low | $67.00 |
| Low Change | -0.12 (-0.18%) |
| High | $67.12 |
| High Change | +0.00 (+0.00%) |
| Range | $0.12 |
| Volume | 11.747K |
| Dollar Volume | $788.22K |
Regular Trading Hours Yesterday
-2.13(-3.08%)
| Open | $69.21 |
|---|---|
| Close | $67.08 |
| Low | $66.31 |
| Low Change | -2.91 (-4.20%) |
| High | $69.66 |
| High Change | +0.45 (+0.65%) |
| Range | $3.36 |
| Volume | 1.63M |
| Dollar Volume | $109.31M |
Premarket Yesterday
-0.31(-0.45%)
| Open | $69.04 |
|---|---|
| Close | $68.73 |
| Low | $68.46 |
| Low Change | -0.58 (-0.84%) |
| High | $69.04 |
| High Change | +0.00 (+0.00%) |
| Range | $0.58 |
| Volume | 708 |
| Dollar Volume | $48.66K |
Halozyme Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $68.74 |
|---|---|
| 10 Day Moving Average (SMA10) | $66.98 |
| 20 Day Moving Average (SMA20) | $66.36 |
| 50 Day Moving Average (SMA50) | $65.58 |
| 100 Day Moving Average (SMA100) | $69.00 |
| 200 Day Moving Average (SMA200) | $68.81 |
Halozyme Therapeutics Statistics
| Average Volume (30 Days) | 1.59M |
|---|---|
| P/E Ratio (Current) | 23.54 |
| EPS (Current) | $2.94 |
| Dividend Yield | 0.00% |
| Free Cash Flow | $667.65M |
| Cash Ratio | 0.85 |
| Current Ratio | 2.76 |
| Quick Ratio | 2.33 |
| Debt to Equity | 9.76 |
| Enterprise Value | $10.04B |
| EV to EBITDA | 10.61 |
| EV to Sales | 6.66 |
| Price to Book | 37.38 |
| Price to Cash Flow | 12.12 |
| Price to Free Cash Flow | 12.30 |
| Price to Sales | 5.44 |
| Return on Assets | 0.13% |
| Return on Equity | 1.59% |
Halozyme Therapeutics Stock Splits
There have been no stock splits for Halozyme Therapeutics (HALO).
Halozyme Therapeutics Dividends
There have been no dividends for Halozyme Therapeutics (HALO).